Short interest in Arcutis Biotherapeutics Inc (NASDAQ:ARQT) decreased during the last reporting period, falling from 28.06M to 27.76M. This put 29.34% of the company's publicly available shares short.

Short interest for Arcutis Biotherapeutics gives investors a sense of the degree to which investors are betting on the decline of Arcutis Biotherapeutics's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 1.66M shares traded per day, it would take 16.71 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.